Franz-Werner Haas is the founder of LimmaTech Biologics. LimmaTech Biologics has raised $37M in total funding. Latest round: Series A.
Dr. Franz-Werner Haas is the CEO of LimmaTech Biologics AG, a Swiss biotechnology company. He joined as CEO in July 2023 after LimmaTech was spun out of GlycoVaxyn. Under his leadership, the company completed a $37 million Series A round and later entered an acquisition agreement with Eli Lilly.
Full founder directory · Investor directory · Company funding database · Fundraising library